NCT07306975Not yet recruitingNot Applicable
Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Assiut University
- Enrollment
- 80
- Primary Endpoint
- -To measure SUVs by using different correction methods in oncological PET/CT imaging.
Study Overview
Brief Summary
-To measure SUVs by using different correction methods in oncological PET/CT imaging.
Detailed Description
-To compare between SUV measurements in the tumor and liver using different standardizing parameters such as: body weight, lean body mass and body surface area.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Cancer patients (> 18 years old) referred to nuclear medicine unit to do F18-FDG PET/CT study.
Exclusion Criteria
- •Patients < 18 years old.
- •Patients with increased FDG uptake on tissue associated with non-malignant causes such as diffuse bone marrow FDG uptake or inflammatory.
- •Patients with extensive metastasis.
Outcomes
Primary Outcomes
-To measure SUVs by using different correction methods in oncological PET/CT imaging.
Time Frame: 1/12/2025 to 1/10/2027
-To compare between SUV measurements in the tumor and liver using different standardizing parameters such as: body weight, lean body mass and body surface area.
Secondary Outcomes
- To determine if SUVbsa is more accurate than SUVbw in obese patients.(1/12/2025 to 1/10/2027)
Investigators
Aya Kamel Hamed Ahmed
Resident doctor
Assiut University
Similar Trials
Recruiting
Phase 2
Role of [68Ga]Ga-FAPI PET/CT in oncological patients with doubtful or inconclusive findings at [18F]F-FDG PET/CT2024-518765-96-00Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico200
Recruiting
Not Applicable
Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer HeterogeneityNCT07302763Frederic Pouliot45
Recruiting
Phase 3
[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary origin2023-505592-69-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)50
Recruiting
Phase 2
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients with Neuroendocrine Neoplasms2024-516156-18-00Rigshospitalet200
Recruiting
Phase 3
Evaluating the roLe of Multiplexed PET Imaging in the detection and staging of hepatocellulaR carcinoma and gAstro-entero-pancreatic tumors: a basket diagnostic performance studyhepatocellulaR carcinoma2024-519505-35-00Centre Hospitalier Universitaire De Nantes28